Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer: The 10-year results of a prospective phase II trial

By Budach V.   Becker E.-T.   Boehmer D.   Badakhshi H.   Jahn U.   Wernecke K.-D.   Stromberger C.  

Strahlentherapie und Onkologie, Vol. 190, Iss. 3, 2014-03 ,pp. : 250-255

Springer Publishing Company

Access to resources Recommend Favorite

IMRT Reirradiation with Concurrent Cetuximab Immunotherapy in Recurrent Head and Neck Cancer

By Zwicker Felix   Roeder Falk   Thieke Christian   Timke Carmen   Münter Marc   Huber Peter   Debus Jürgen  

Strahlentherapie und Onkologie, Vol. 187, Iss. 1, 2011-01 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of pre-therapy ¹⁸F-FDG PET/CT for the outcome of ¹⁸F-FDG PET-guided radiotherapy in patients with head and neck cancer

By Picchio M.   Kirienko M.   Mapelli P.   Dell’Oca I.   Villa E.   Gallivanone F.   Gianolli L.   Messa C.   Castiglioni I.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 21-31

Springer Publishing Company

Access to resources Recommend Favorite

Tumour hypoxia imaging with [¹⁸F]FAZA PET in head and neck cancer patients: a pilot study

By Souvatzoglou M.   Grosu A.   Röper B.   Krause B.   Beck R.   Reischl G.   Picchio M.   Machulla H.-J.   Wester H.-J.   Piert M.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1566-1575

Springer Publishing Company

Access to resources Recommend Favorite

Outcome after Re-Irradiation of Head and Neck Cancer Patients

By Platteaux Nele   Dirix Piet   Vanstraelen Bianca   Nuyts Sandra  

Strahlentherapie und Onkologie, Vol. 187, Iss. 1, 2011-01 ,pp. : 23-31

Springer Publishing Company

Access to resources Recommend Favorite